Breaking News Instant updates and real-time market news.

DBVT

DBV Technologies

$35.42

0.54 (1.55%)

07:22
03/21/17
03/21
07:22
03/21/17
07:22

Morgan Stanley to hold a conference

Healthcare Corporate Access Day is being held in Boston on March 21.

  • 21

    Mar

DBVT DBV Technologies
$35.42

0.54 (1.55%)

01/05/17
JEFF
01/05/17
NO CHANGE
JEFF
Celgene, Alkermes among Jefferies' top 2017 Biotech picks
Jefferies' Biotechnology equity research team laid out their top picks for 2017. Following a volatile two years, the biotech space seeks to achieve "greater equilibrium" in 2017, the analysts write in a research note. They cite increasing competition, slowing volumes, and ramping payer leverage as reasons to remain selective when picking stocks this year and beyond. Among large-caps, Jefferies likes Celgene (CELG) for its "best-in-class growth" and sees limited downside in Gilead (GILD) shares. In the mid-cap space, the firm favors Alkermes (ALKS) given the prospects for Vivitrol and Aristada and a "strong" neurology pipeline as well as Vertex (VRTX). Jefferies' top small-cap picks include Aevi Genomics Medicine, Alder Biopharmaceuticals (ALDR), AMAG Pharmaceuticals (AMAG), DBV Technologies (DBVT), Immunomedics (IMMU), Ignyta (RXDX), Karyopharm (KPTI), RA Pharmaceuticals (RARX), TherapeuticsMD (TXMD) and Xenon Pharmaceuticals (XENE).
02/17/17
PIPR
02/17/17
NO CHANGE
Target $40
PIPR
Overweight
Piper sees Aimmune trial changes as reducing clinical risk
Piper Jaffray analyst Charles Duncan believes the Phase III change announced yesterday by Aimmune Therapeutics (AIMT) reduces clinical risk for the trial read-out, while still addressing a broad group of children and teens more broadly relative to Aimmune's "mindshare competitor" DBV Technologies (DBVT). The PALISADE Phase III primary analysis and initial BLA application will now include ages 4-17, but exclude adult patients, Duncan tells investors in a research note. Following the news, the analyst still believes Aimmune's AR101 will be approved and used in some of adult patients, but points out another trial may be required. He pushed his first AR101 sales estimate in adults back by two years to 2021 in the U.S. market and 2020 to 2022 in the E.U. market. Duncan keeps an Overweight rating on Aimmune with a $40 price target.
02/17/17
NTXS
02/17/17
UPGRADE
NTXS
Buy
DBV Technologies upgraded to Buy from Neutral at Natixis (earlier)
Natixis analyst Jeanjacques Le Fur earlier today upgraded DBV Technologies to Buy with a price target of EUR 92. The analyst has confidence in the company's Phase 3 Viaskin patch for peanut allergy study that is expected to readout this year. DBV shares in morning trading are up 5% to $36.23.
03/16/17
SOCG
03/16/17
UPGRADE
SOCG
Buy
DBV Technologies upgraded to Buy from Hold at Societe Generale
Societe Generale analyst Delphine Le Louet upgraded DBV Technologies to Buy with an increased price target of EUR 82.

TODAY'S FREE FLY STORIES

MRK

Merck

$64.16

0.375 (0.59%)

11:25
05/22/17
05/22
11:25
05/22/17
11:25
Hot Stocks
Merck says Phase 2 study results warrant continued evaluation of MK-7264 »

Merck announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 27

    May

  • 31

    May

  • 02

    Jun

  • 05

    Jun

  • 09

    Jun

  • 14

    Jun

LC

LendingClub

$5.92

0.26 (4.59%)

, ONDK

On Deck Capital

$3.71

0.32 (9.44%)

11:23
05/22/17
05/22
11:23
05/22/17
11:23
Periodicals
Online lendeers attract bond buyers, WSJ says »

According to…

LC

LendingClub

$5.92

0.26 (4.59%)

ONDK

On Deck Capital

$3.71

0.32 (9.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    May

  • 27

    Jun

  • 28

    Jun

  • 29

    Jun

MGM

MGM Resorts

$31.66

0.41 (1.31%)

11:20
05/22/17
05/22
11:20
05/22/17
11:20
Options
Notable option blocks in MGM »

Notable option blocks in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
05/22/17
05/22
11:17
05/22/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

11:16
05/22/17
05/22
11:16
05/22/17
11:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTBC

Medical Transcription Billing

$1.90

0.02 (1.06%)

11:15
05/22/17
05/22
11:15
05/22/17
11:15
Hot Stocks
MTBC jumps after announcing releases of app for smartphones »

Earlier today, MTBC…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

3-Month Bill Auction to…

11:15
05/22/17
05/22
11:15
05/22/17
11:15
General news
Breaking General news story  »

6-Month Bill Auction to…

XOM

Exxon Mobil

$82.08

0.147 (0.18%)

11:13
05/22/17
05/22
11:13
05/22/17
11:13
Hot Stocks
Exxon Mobil completes polyethylene lines at Texas plant »

ExxonMobil Chemical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

XOP

SPDR Oil Exploration and Production Fund

$35.37

-0.15 (-0.42%)

11:10
05/22/17
05/22
11:10
05/22/17
11:10
Options
Upside call buying in SPDR Oil Exploration and Production ETF »

Upside call buying in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:10
05/22/17
05/22
11:10
05/22/17
11:10
General news
Treasury announced a $55 B 4-week bill auction for Tuesday »

Treasury announced a $55…

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Orbotech sinks after disclosing criminal probe by Israel Tax Authority »

Orbotech earlier today…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

AVY

Avery Dennison

$83.18

0.42 (0.51%)

11:09
05/22/17
05/22
11:09
05/22/17
11:09
Hot Stocks
Avery Dennison acquires Finesse Medical »

Avery Dennison…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ORBK

Orbotech

$36.72

0.35 (0.96%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Downgrade
Orbotech rating change  »

Orbotech downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 24

    May

RPT

Ramco-Gershenson

$12.75

-0.16 (-1.24%)

11:08
05/22/17
05/22
11:08
05/22/17
11:08
Conference/Events
Ramco-Gershenson management to meet with Jefferies »

Meeting to be held in Las…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

AVT

Avnet

$36.98

-0.1099 (-0.30%)

11:06
05/22/17
05/22
11:06
05/22/17
11:06
Hot Stocks
Avnet named exclusive global distributor for Silego Technology »

Avnet and Silego…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:05
05/22/17
05/22
11:05
05/22/17
11:05
General news
4-Week Bill Announcement Offering Amount data reported »

4-Week Bill Announcement…

RARX

RA Pharmaceuticals

$24.62

-0.32 (-1.28%)

11:04
05/22/17
05/22
11:04
05/22/17
11:04
Conference/Events
RA Pharmaceuticals management to meet with Jefferies »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

  • 24

    May

  • 25

    May

  • 22

    Jun

BBRY

BlackBerry

$10.38

0.27 (2.67%)

11:00
05/22/17
05/22
11:00
05/22/17
11:00
Options
Blackberry calls active as the rally continues »

Blackberry calls active…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Jun

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:58
05/22/17
05/22
10:58
05/22/17
10:58
Conference/Events
Quotient Technology management to meet with Maxim »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

QUOT

Quotient Technology

$11.30

0.05 (0.44%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Conference/Events
Quotient Technology management to meet with Loop »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

RHHBY

Roche

$34.30

0.495 (1.46%)

10:57
05/22/17
05/22
10:57
05/22/17
10:57
Hot Stocks
FDA approves Roche's Actemra for giant cell arteritis »

Genentech, a member of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 06

    Jun

  • 26

    Jun

PQ

PetroQuest

$2.42

0.1285 (5.61%)

10:56
05/22/17
05/22
10:56
05/22/17
10:56
Conference/Events
PetroQuest management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 25

    May

C

Citi

$60.95

-0.15 (-0.25%)

10:53
05/22/17
05/22
10:53
05/22/17
10:53
Hot Stocks
Citi releases statement on settlement with DOJ over BUSA »

Citi issued the following…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

  • 25

    Jul

PLNT

Planet Fitness

$20.81

0.13 (0.63%)

10:51
05/22/17
05/22
10:51
05/22/17
10:51
Conference/Events
Planet Fitness management to meet with William Blair »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 24

    May

  • 20

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.